The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Pulmonary toxicities in patients (pts) with metastatic breast cancer (mBC) treated with trastuzumab deruxtecan (T-DXd): The Mayo Clinic experience.
 
Jenna Hoppenworth
Consulting or Advisory Role - AstraZeneca
 
Sarah Premji
No Relationships to Disclose
 
Deanne R. Smith
No Relationships to Disclose
 
Jodi L. Taraba
Consulting or Advisory Role - AstraZeneca; Change Healthcare; Lilly; Lilly; Lilly; MJH Life Sciences; Novartis
 
Timothy J. Hobday
Research Funding - Novartis (Inst)
 
Prema P. Peethambaram
No Relationships to Disclose
 
Jamie Carroll
Honoraria - Clinical Care Options; OncLive/MJH Life Sciences; Peer View; Research to practice
Speakers' Bureau - AstraZeneca (Inst); Lilly (Inst); Novartis; Sermonix Pharmaceuticals (Inst)
 
Kathryn Jean Ruddy
Research Funding - Medtronic (I)
Patents, Royalties, Other Intellectual Property - Spouse and Mayo Clinic have filed patents related to the application of artificial intelligence to the electrocardiogram for diagnosis and risk stratification. (I)
 
Ciara Catherine O'Sullivan
Honoraria - AstraZeneca (Inst); Medscape (Inst); Seagen (Inst); Seagen (Inst)
Research Funding - Academic & Community Cancer Research United (Inst); Bavarian Nordic (Inst); Eisai (Inst); Genentech (Inst); Lilly (Inst); nference (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tesaro (Inst)
Patents, Royalties, Other Intellectual Property - nFerence Astra Zeneca (Inst)
 
Amye Juliet Tevaarwerk
Other Relationship - Epic Systems (I)
 
Grace Mei Yee Choong
No Relationships to Disclose
 
Elizabeth Jane Cathcart-Rake
No Relationships to Disclose
 
Siddhartha Yadav
Research Funding - AstraZeneca (Inst); REPARE Therapeutics (Inst)
(OPTIONAL) Uncompensated Relationships - AstraZeneca
 
Lisa Ellsworth
No Relationships to Disclose
 
Rohit Rao
No Relationships to Disclose
 
Ashley Egan
No Relationships to Disclose
 
Tufia C. Haddad
Consulting or Advisory Role - Puma Biotechnology (Inst)
Research Funding - Takeda (Inst)
 
Matthew P. Goetz
Consulting or Advisory Role - ARC Therapeutics (Inst); AstraZeneca (Inst); BioTheryX; Blueprint Medicines (Inst); Engage Health Media (Inst); Genzyme (Inst); Laekna Therapeutics; Lilly (Inst); Novartis (Inst); Rna Diagnostics (Inst); Seagen (Inst); Sermonix Pharmaceuticals (Inst); Tersera
Research Funding - AstraZeneca (Inst); Atossa Genetics (Inst); Lilly (Inst); Loxo (Inst); Pfizer (Inst); Sermonix Pharmaceuticals (Inst)
Patents, Royalties, Other Intellectual Property - Development of Human Tumor Xenografts from Women with Breast Cancer Treated with Neoadjuvant Chemotherapy (Inst); Methods and Materials for Assessing Chemotherapy Responsiveness and Treating Cancer; METHODS AND MATERIALS FOR USING BUTYRYLCHOLINESTERASES TO TREAT CANCER
Travel, Accommodations, Expenses - Lilly (Inst)
 
Karthik Giridhar
Consulting or Advisory Role - AstraZeneca/Daiichi Sankyo (Inst); Exact Sciences (Inst); Gilead Sciences (Inst); Lilly (Inst); MJH Live Events (Inst); MJH Live Events (Inst); NeoGenomics Laboratories (Inst); Puma Biotechnology (Inst); Tersera (Inst)
Research Funding - Guardant Health (Inst); Pfizer (Inst)
Travel, Accommodations, Expenses - GRAIL; QuantumLeap Health
 
Roberto Antonio Leon-Ferre
Consulting or Advisory Role - AstraZeneca (Inst); Gilead Sciences (Inst); Lyell Immunopharma (Inst)